Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New York City, New York 10035


Purpose:

This is an open label pre-post study of the effects of clinical treatment with varenicline on 1) decreasing smoking in schizophrenic patients, 2) improving selected cognitive measures in schizophrenic patients, and 3) effects nicotinic binding to leukocytes and DNMT1 mRNA in lymphocytes. Patients are assessed on subjective and objective measures of smoking , selected cognitive measures, and special chemical measures, during baseline testing and during 8 weeks of treatment with varenicline ( 1-3 mg/day).


Criteria:

Inclusion Criteria: - Clinical Diagnosis of Schizophrenia or Schizoaffective Psychosis - Recent History of Cigarette smoking - Ages 18-65


NCT ID:

NCT00548470


Primary Contact:

Principal Investigator
Robert C Smith, MD, PhD
Nathan Kline insitutue fo Psychiatric Research; NYU School of Medicine


Backup Contact:

N/A


Location Contact:

New York City, New York 10035
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 22, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.